Jafron Biomedical Co.,Ltd. (300529.SZ)
CNY 30.04
(-0.07%)
CNY 30.04
(-0.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.92 Billion | 2.49 Billion | 2.67 Billion | 1.95 Billion | 1.43 Billion | 1.01 Billion |
| Cost of Revenue | 383.98 Million | 440.1 Million | 402.06 Million | 287.96 Million | 197.39 Million | 154.44 Million |
| Gross Profit | 1.53 Billion | 2.05 Billion | 2.27 Billion | 1.66 Billion | 1.23 Billion | 862.06 Million |
| Operating Expenses | 994.54 Million | 1.04 Billion | 891.09 Million | 648.88 Million | 596.34 Million | 428.04 Million |
| Selling, General and Administrative Expenses | 664.42 Million | 732.99 Million | 629.63 Million | 493.71 Million | 454 Million | 322.22 Million |
| Research and Development Expenses | 245.37 Million | 253.9 Million | 173.77 Million | 80.75 Million | 68.45 Million | 46.13 Million |
| Other Expenses | 5.77 Million | 59.61 Million | 87.68 Million | 74.41 Million | 73.88 Million | -3.17 Million |
| Cost and Expenses | 1.37 Billion | 1.48 Billion | 1.29 Billion | 936.84 Million | 793.73 Million | 582.48 Million |
| Operating Income | 543.81 Million | 1.02 Billion | 1.41 Billion | 1.05 Billion | 680.32 Million | 476.3 Million |
| Interest Expense | 55.28 Million | 36.04 Million | 8.9 Million | 1.28 Million | 233.5 Thousand | 140.57 Thousand |
| Income Tax Expense | 95.29 Million | 135.88 Million | 211.37 Million | 158.95 Million | 102.58 Million | 72.19 Million |
| Earnings before Tax | 521.02 Million | 1.01 Billion | 1.4 Billion | 1.03 Billion | 671.28 Million | 473.13 Million |
| Net Income | 436.49 Million | 889.56 Million | 1.19 Billion | 875.24 Million | 570.82 Million | 401.97 Million |
| Earnings Per Share Basic | 0.55 | 1.12 | 1.49 | 1.10 | 0.72 | 0.51 |
| Earnings Per Share Diluted | 0.55 | 1.12 | 1.49 | 1.08 | 0.72 | 0.51 |
| Weighted Average Shares Outstanding | 793.62 Million | 797.82 Million | 803.23 Million | 795.67 Million | 791 Million | 787.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 793.62 Million | 797.82 Million | 803.23 Million | 810.4 Million | 791 Million | 787.38 Million |
| Gross Margin | 0.80 | 0.82 | 0.85 | 0.85 | 0.86 | 0.85 |
| EBIT Margin | 0.36 | 0.45 | 0.55 | 0.54 | 0.49 | 0.49 |
| Profit Margin | 0.23 | 0.36 | 0.45 | 0.45 | 0.40 | 0.40 |
| EBITDA | 689.28 Million | 1.13 Billion | 1.48 Billion | 1.07 Billion | 702.32 Million | 495.45 Million |
| Earnings Before Tax Margin | 0.28 | 0.41 | 0.53 | 0.54 | 0.48 | 0.47 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 700.06 Million | 738.98 Million | 732.67 Million | 436.36 Million | 1.92 Billion | 473.83 Million |
| Cost of Revenue | 119.22 Million | 150.54 Million | 158.65 Million | 96.63 Million | 383.98 Million | 90.48 Million |
| Gross Profit | 580.83 Million | 588.43 Million | 574.01 Million | 339.73 Million | 1.53 Billion | 383.34 Million |
| Operating Expenses | 268.98 Million | 275.62 Million | 252.41 Million | 296.49 Million | 1.01 Billion | 215.01 Million |
| Selling, General and Administrative Expenses | 436.65 Million | 227.77 Million | 198.24 Million | 110.72 Million | - | 218.98 Million |
| Research and Development Expenses | 61.93 Million | 47.85 Million | 54.17 Million | 69.02 Million | - | 61.73 Million |
| Other Expenses | -229.59 Million | -7.94 Million | -8.78 Million | -6.55 Million | -22.79 Million | -5.78 Million |
| Cost and Expenses | 388.21 Million | 426.16 Million | 411.07 Million | 393.12 Million | 1.39 Billion | 305.5 Million |
| Operating Income | 307.37 Million | 312.81 Million | 321.59 Million | 28.68 Million | 543.81 Million | 175.6 Million |
| Interest Expense | 15.38 Million | 16.2 Million | 16.35 Million | 14.04 Million | 54.33 Million | 15.06 Million |
| Income Tax Expense | 56.29 Million | 53.49 Million | 56 Million | 16.84 Million | 95.29 Million | 24.59 Million |
| Earnings before Tax | 294.36 Million | 320.31 Million | 339.93 Million | 22.13 Million | 521.02 Million | 169.82 Million |
| Net Income | 239.12 Million | 267.73 Million | 284.76 Million | 12.83 Million | 436.49 Million | 146.14 Million |
| Earnings Per Share Basic | 0.30 | 0.35 | 0.36 | 0.02 | - | 0.19 |
| Earnings Per Share Diluted | 0.29 | 0.33 | 0.35 | 0.05 | - | 0.18 |
| Weighted Average Shares Outstanding | 786.15 Million | 770.86 Million | 783.31 Million | 776.44 Million | 793.62 Million | 789.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 824.58 Million | 810.1 Million | 814.78 Million | 814.72 Million | 765.77 Million | 811.92 Million |
| Gross Margin | 0.83 | 0.80 | 0.78 | 0.78 | 0.80 | 0.81 |
| EBIT Margin | 0.44 | 0.47 | 0.48 | 0.13 | - | 0.39 |
| Profit Margin | 0.34 | 0.36 | 0.39 | 0.03 | 0.23 | 0.31 |
| EBITDA | 309.75 Million | 346.35 Million | 355.27 Million | 57.76 Million | - | 186.55 Million |
| Earnings Before Tax Margin | 0.44 | 0.42 | 0.44 | 0.07 | 0.28 | 0.37 |
2449
RADIANTCMS
SNWS
000498
HTRC
SMIFS